🏥Public HealthFDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee
The White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
🏥Public HealthThe White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
🧠AI AnalysisThe European Commission's proposed amendments to the Medical Device Regulation aim to cut administrative hurdles, though experts note specific challenges for artificial i…
🏥Public HealthThe Trump administration has proposed new health regulations aimed at curbing fraud, with projected savings of $90 billion over the next decade derived entirely from incr…
🧠AI AnalysisThe CDC is operating with permanent directors in only four of its twelve centers, with some leadership announcements now delayed until 2027.
🏥Public HealthFollowing earlier pauses and funding cuts, the U.S. State Department has introduced the America First Global Health Strategy, tying foreign aid more directly to U.S. nati…
🏥Public HealthNumerous states are utilizing federal funding to attract medical professionals to underserved rural areas through service-commitment programs, though questions persist re…
🏥Public HealthThe appointment of Stephen Miller as White House chief of staff has revitalized health secretary Robert F. Kennedy Jr.'s 'Make America Healthy Again' initiative following…
🏥Public HealthFederal officials announced that states have until July to begin removing individuals from Medicaid for failing to meet new work mandates, easing initial administrative h…
🏥Public HealthDemocratic lawmakers in Washington are increasingly supporting proposals to broaden Medicare access and introduce a 'Medikids' program for children and young adults as a …
🧠AI AnalysisFederal guidelines lack a standardized verification system for Native American Medicaid work requirement exemptions, raising concerns about potential coverage losses.
🏥Public HealthMedical experts writing in The BMJ caution that pharmaceutical-backed campaigns aimed at reducing obesity stigma may shift public policy toward a purely medicalized appro…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.